info@marketresearchfuture.com   ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Osgood-Schlatter Market Research Report Information: By Diagnosis (Physical Examination, Ultrasonography, X-Ray, Combination), Treatment (Non-Steroidal Anti-Inflammatory Drugs, Physical Therapy, Knee Braces and Supports, Surgery), End-User - Forecast till 2032


ID: MRFR/Pharma/3304-HCR | 110 Pages | Author: Rahul Gotadki| July 2024

Osgood-Schlatter Market Overview 


Osgood-Schlatter Market Size was valued at USD 2.97 Billion in 2023. The Global Osgood-Schlatter industry is projected to grow from USD 3.73 Billion in 2024 to USD 6.57 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.12% during the forecast period (2024 - 2032). 


Osgood-Schlatter Market


Osgood–Schlatter disease (OSD), is the inflammation of area below the knee characterized by a painful bump just below the knee which worsens with activity. OSD typically affects growing adolescents during puberty and is common in those participating in sports and other physical activities. OSD causes a painful lump below the kneecap, resulting in swelling and tenderness affecting the knee. Risk factors include high intensity sports such as running or jumping.


OSD generally resolves with time especially with rest. OSD affects 4% of people at least once in their lifetime and is more common in males between the ages of 10 and 15. The male to female ratio is approximately 5:1.


The symptoms of OSD includes knee pain, swelling, tenderness, increased warmth under the knee and others. In extreme cases OSD may result in fracture.


The market drivers for Osgood-Schlatter market are rise in population, increasing awareness and screening, development of healthcare and orthopaedic centres, rise in sports culture, growth of physiotherapy and advancements in drugs and surgery etc. The market restraints are the complications of treatment such as pain, bleeding, high cost of treatment, competition from alternative treatment and self-correcting nature of the disease etc.


Intended Audience



  • Global Osgood-Schlatter manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


Osgood-Schlatter Market Segmentation


The Osgood-Schlatter market has been segmented on the basis of diagnosis, treatment and end user.


Based on the diagnosis, the Osgood-Schlatter market has been segmented as physical examination, ultrasonography, X-ray, combination, and other.


Based on the treatment, the Osgood-Schlatter market has been segmented as non-steroidal anti-inflammatory drugs, physical therapy, knee braces and supports, surgery, and others.


Based on the end user, the Osgood-Schlatter market has been segmented as hospitals & clinics, academic and research, and others.


Osgood-Schlatter Market Regional Analysis


The Americas account for a significant market share owing to high expenditure on the health care. Additionally, the fastest uptake of new healthcare products in the US drives the Osgood-Schlatter market. Furthermore, concentration of the major healthcare companies and hospitals in the developed countries of this region coupled with large insurance penetration is adding fuel to the market growth. Moreover, the US expend high amount on its healthcare, which accounts for 16% of total GDP, which also increases the sale in Osgood-Schlatter market.


Europe is the second largest market in the world due to high income and strong healthcare penetration. The European market growth is led by countries such as Germany and France. The UK is expected to be the fastest growing market over the assessment period. The strong pharmaceutical industry in Germany is a strong driver behind the dominance of this country in Europe.


The large sporting culture and popularity of sports and media influence in the developed regions is expected to drive the future market.


Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare insurance in the Asia Pacific region is expected to drive the future Osgood-Schlatter market in the region.


Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is expected to witness a moderate growth owing to poor economic and political conditions, and poor healthcare development.


Key Players in the Global Osgood-Schlatter Market


Some of the key players profiled in the Osgood-Schlatter market report are: 



  • DJO Global, Inc.

  • Teva Pharmaceutical Industries Ltd.

  • Breg, Inc.

  • Bayer HealthCare Pharmaceuticals LLC

  • Ossur HF

  • Daiichi Sankyo Company, Limited

  • Pfizer, Inc.

  • Novartis AG

Report Attribute/Metric Details
  Market Size   2032: USD 6.57 Billion
  CAGR   6.12% (2024-2032)
  Base Year   2023
  Forecast Period   2024-2032
  Historical Data   2022
  Forecast Units   Value (USD Billion)
  Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered Diagnosis, Treatment and End User
  Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors DJO Global, Inc., Teva Pharmaceutical Industries Ltd., Breg, Inc., Bayer HealthCare Pharmaceuticals LLC, Ossur HF, Daiichi Sankyo Company, Limited, Pfizer, Inc., Novartis AG, and others
  Key Market Opportunities New product launches and R&D Amongst major key Players
  Key Market Drivers Rise in population Increasing awareness and screening Development of healthcare and orthopaedic centres Rise in sports culture Growth of physiotherapy Advancements in drugs and surgery


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.